Abstract

Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia.
Karin M Abernathy ... Matthew A Perciavalle
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | VOL. 29
Karin M Abernathy, et. al.Karin M Abernathy ... Matthew A Perciavalle
09 Aug 2022
Spermidine/spermine N1-acetyltransferase activity associates with white blood cell count in myeloid leukemias
Satu Mustjoki ... Anne Uimari
Experimental Hematology | VOL. 42
Satu Mustjoki, et. al.Satu Mustjoki ... Anne Uimari
04 Mar 2014
Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up
Patrick W Burke ... Anthony J Perissinotti
Leukemia & Lymphoma | VOL. 65
Patrick W Burke, et. al.Patrick W Burke ... Anthony J Perissinotti
28 Oct 2023
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study.
Christoph Losem ... Johannes Hülsenbeck
Annals of hematology | VOL. 103
Christoph Losem, et. al.Christoph Losem ... Johannes Hülsenbeck
29 Feb 2024
View more papers

More From: American journal of hematology

Paper Title
Journal
Date
Author
A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
Richard Allen ... Huzefa Bahrain
American journal of hematology | VOL. 99
Richard Allen, et. al.Richard Allen ... Huzefa Bahrain
01 Jun 2024
-
-
American Journal of Hematology | VOL. 99
--
01 Jun 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Matthew Mei
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Matthew Mei
28 May 2024
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Paul Koller
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Paul Koller
27 May 2024
View more papers